Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial ResultsBusiness Wire • 04/15/21
Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping TestBusiness Wire • 04/14/21
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/18/21
Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness Wire • 02/11/21
Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021Business Wire • 02/10/21
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 02/09/21
Veracyte Raises $550M In Upsized Equity Offering For Decipher Biosciences AcquisitionBenzinga • 02/05/21
Veracyte Announces Pricing of Upsized Public Offering of 7,432,433 Shares of Common StockBusiness Wire • 02/05/21
Veracyte Scoops Up Decipher Biosciences For $600M, Reports Fourth Quarter Interim ResultsBenzinga • 02/03/21
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial ResultsBusiness Wire • 02/03/21
Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid CancerBusiness Wire • 12/22/20